Overview

Study to Determine Dosage of OPTISON in Pediatric Patients

Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
Study to determine the safety and appropriate dosage of OPTISON in pediatric patients since OPTISON has been tested in adult patients only during the clinical development
Phase:
Phase 4
Details
Lead Sponsor:
GE Healthcare
Collaborators:
Chiltern International Inc.
Covance